Tulane Cancer Center

Tulane University School of Medicine

New Orleans, LA

Sorting 1 by

Accepting patients

Etentamig

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 1
  • Has results
1 hidden based on your filters.Show All